<span item_type="fundamental" item_id="a55e76f88361b6fdf1643b0c4da2bb26" counter_id="ST/US/LPAAW" env="prod"></span><span item_type="announcement" item_id="549449685920060929" env="prod"></span><p>EPS: As of FY2025 Q2, the actual value is USD 0.07.</p><p></p><h3>Segment Revenue</h3><ul><li><strong>Interest Earned on Trust Account</strong>: For the three months ended June 30, 2025, interest earned was $2,547,714, and for the six months ended June 30, 2025, it was $4,996,750.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025076716/ea0252211-10q_launch1.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Income</strong>: For the three months ended June 30, 2025, net income was $1,922,018, compared to a net loss of $22,202 for the same period in 2024. For the six months ended June 30, 2025, net income was $4,209,431, compared to a net loss of $40,388 for the period from February 21, 2024, through June 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025076716/ea0252211-10q_launch1.htm"></span></li><li><strong>General and Administrative Expenses</strong>: For the three months ended June 30, 2025, expenses were $637,837, and for the six months ended June 30, 2025, they were $815,879.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025076716/ea0252211-10q_launch1.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Used in Operating Activities</strong>: For the six months ended June 30, 2025, net cash used in operating activities was - $586,598.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025076716/ea0252211-10q_launch1.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company is focused on completing the Minovia Business Combination, which involves merging with Minovia Therapeutics Ltd. and becoming a wholly-owned subsidiary of Pubco, a publicly traded company on Nasdaq.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025076716/ea0252211-10q_launch1.htm"></span></li><li><strong>Non-Core Business</strong>: The company is also involved in bridge financing efforts to raise at least $5 million for Minovia at a pre-money equity valuation of $120 million.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025076716/ea0252211-10q_launch1.htm"></span></li></ul><h3>Priority</h3><ul><li>The company emphasizes the completion of the Minovia Business Combination and the associated financing activities as its primary strategic focus.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2015502/000121390025076716/ea0252211-10q_launch1.htm"></span></li></ul>

LAUNCH ONE ACQUISITION CORP C/ WTS 01/06/2031 (TO PUR ORD) | 10-Q: FY2025 Q2 EPS: USD 0.07